机构:[1]Department of Obstetrics and Gynecology, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.[2]Geriatric Disease Institute of Chengdu, Cancer Prevention and Treatment institute of Chengdu, Chengdu, China.[3]Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
第一作者机构:[1]Department of Obstetrics and Gynecology, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.[2]Geriatric Disease Institute of Chengdu, Cancer Prevention and Treatment institute of Chengdu, Chengdu, China.
通讯作者:
通讯机构:[1]Department of Obstetrics and Gynecology, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.[2]Geriatric Disease Institute of Chengdu, Cancer Prevention and Treatment institute of Chengdu, Chengdu, China.
推荐引用方式(GB/T 7714):
Shuai Xu,Xiao Dan,Han Binhua,et al.Type and approach of hysterectomy and oncological survival of women with stage II cancer of endometrium: a large retrospective cohort study[J].Frontiers In Oncology.2024,14:1404831.doi:10.3389/fonc.2024.1404831.
APA:
Shuai Xu,Xiao Dan,Han Binhua&Du Yixue.(2024).Type and approach of hysterectomy and oncological survival of women with stage II cancer of endometrium: a large retrospective cohort study.Frontiers In Oncology,14,
MLA:
Shuai Xu,et al."Type and approach of hysterectomy and oncological survival of women with stage II cancer of endometrium: a large retrospective cohort study".Frontiers In Oncology 14.(2024):1404831